BackAstellas Pharma Overview

Astellas Pharma Research & Development

Research & Development expenses for ALPMY.

Quarterly R&D Expenses

$-221496691000.00
↓ 390.57% YoY

As of Mar 31, 2026

Annual R&D Expenses (TTM)

$-72353544785.00
↓ 122.08% YoY

Trailing 12 months ending Mar 31, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin